The health secretary says he will balance the arguments for and against mass testing ahead of a final decision due in March.

It recommends that only men with a confirmed genetic risk of prostate cancer should be screened for the disease.

A groundbreaking trial for a prostate cancer treatment has been launched in the UK, with the hope of reducing the side ...

Indiana University is leading the way in the development of groundbreaking nanotechnology to revolutionize screening for prostate cancer, the second leading cause of cancer death among men in the ...

LOS ANGELES--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) announced the recipients of its 2024 Challenge Awards, funding over $16 million in innovative prostate cancer research for ...

Official recommendations that discourage use of hotly debated screening test could be linked to increase, experts suggest ...

New research highlights a significant link between low vitamin D levels and more aggressive prostate cancer. Studies indicate vitamin D supports cell regulation and DNA repair, with deficiency ...

Prostate cancer decision by UK National Screening Committee is expected to reject offering PSA test to Black men and those ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

Canadian research suggests recommendations against screening for prostate cancer has led to a rise in the rates of stage 4 ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

The former PM is calling for more men to be screened for the disease, which is the most common cancer in males in the UK.